Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma.

MLA

Yu-Hang Ye, et al. “Development and Validation of a Stromal-Immune Signature to Predict Prognosis in Intrahepatic Cholangiocarcinoma.” Clinical & Molecular Hepatology, vol. 30, no. 4, Oct. 2024, pp. 914–28. EBSCOhost, https://doi.org/10.3350/cmh.2024.0296.

APA

Yu-Hang Ye, Hao-Yang Xin, Jia-Li Li, Ning Li, Si-Yuan Pan, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Peng-Cheng Wang, Chu-Bin Luo, Rong-Qi Sun, Jia Fan, Jian Zhou, Zheng-Jun Zhou, & Shao-Lai Zhou. (2024). Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma. Clinical & Molecular Hepatology, 30(4), 914–928. https://doi.org/10.3350/cmh.2024.0296

Chicago

Yu-Hang Ye, Hao-Yang Xin, Jia-Li Li, Ning Li, Si-Yuan Pan, Long Chen, Jing-Yue Pan, et al. 2024. “Development and Validation of a Stromal-Immune Signature to Predict Prognosis in Intrahepatic Cholangiocarcinoma.” Clinical & Molecular Hepatology 30 (4): 914–28. doi:10.3350/cmh.2024.0296.